Back to Search Start Over

An Overview of Coronavirus Disease (MERS& SARS): COVID-19.

Authors :
S., SHAKIR BASHA
K., SUSMITHA
P., JAGADEESH
K., SUSMEENA TABASSUM
A. H., JUNAID
S., FAYAZ AHMMED
R., ZUBER
S., KHIFAYATHULLA
G., ASWINI
Source :
International Journal of Pharmaceutical Research (09752366). Jan-Mar2021, Vol. 13 Issue 1, p748-755. 8p.
Publication Year :
2021

Abstract

In the year 2019, December, a novel Coronavirus (CoV) was identified in the area of Wuhan City, Hubei, China. Coronavirus is a broad community of viruses which have been proven to produce disorders ranging from a simple cold to even more serious disorders, namely severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS). Epidemiological genomic studies including association with some other Coronaviruses resulted in the emergence of novel Coronaviruses, remotely matching the bat Coronaviruses. In distinct countries, COVID-19 epidemics are yet in the seeding up the stage. The SARS-CoV-2 outbreak would pose a significant threat to the potential survival of public health in 2019&2020. A vaccine against the virus is not yet available. Since the deaths have been increasing and to prevent it from spreading certain measures should be followed. The preventive measures generally include washing your hands regularly, use of facemask, avoid unnecessary contact with animals, and avoid close contact with infected people. Currently, the need for effective instance identification, management, and adequate precautionary measures will be potentially helpful in the management of the epidemic. There are a variety of candidate medications are available, which may inhibit SARS-CoV-2 invasion along with its recombination. The results of the current clinical trials in combination with Hydroxychloroquine, azithromycin, and some other new anti-viral agents such as remdesivir could help to assist a few of the infections, although there is still a long way to go to the results of clinical trials and the use of vaccines in the community healthcare plan. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09752366
Volume :
13
Issue :
1
Database :
Academic Search Index
Journal :
International Journal of Pharmaceutical Research (09752366)
Publication Type :
Academic Journal
Accession number :
155803019
Full Text :
https://doi.org/10.31838/ijpr/2021.13.01.123